There is a narrow way to name a prescription drug in an advertisement and carry nothing else: the reminder advertisement. Under 21 CFR § 202.1(e)(2)(i), reminder advertisements “call attention to the name of the drug product but do not include indications or dosage recommendations for use of the drug product.” They may contain only the proprietary name, the established name of the drug product, and the established name of each active ingredient, with a few optional additions.
Read what that excludes. The moment your ad says what the drug treats, it is not a reminder advertisement, and § 202.1(e)(1) attaches: all advertisements for a prescription drug, other than the exempt categories, “must present a true statement of information in brief summary relating to side effects, contraindications, and effectiveness.”
“Botox for forehead lines” names the drug and states the indication. That is not a reminder ad. Most med spa advertising is written exactly that way.
The line, stated plainly
| Ad copy | Is it a reminder ad? | What attaches |
|---|---|---|
| The brand name, alone, on a price-free graphic | Yes, if nothing else is added | Name and established-name requirements only |
| Brand name plus “for forehead lines” | No, an indication is stated | Brief summary under § 202.1(e)(1) |
| Brand name plus “smooths wrinkles in 3 days” | No, indication plus an effectiveness claim | Brief summary, plus substantiation |
| “Wrinkle treatment,” no brand named | Not a prescription-drug ad at all | Ordinary advertising law |
That last row is the one operators rarely notice. Not naming the drug is a lawful strategy. An advertisement for a service, which does not identify a prescription product, does not walk into § 202.1 at all. A great deal of aesthetic marketing could simply say what the clinic does and never name the molecule.
The established name travels with the brand name
Where the ad does name the product, § 202.1 requires the established name to appear with it. Operators think of this as the manufacturer’s branding preference. It is a federal labeling and advertising requirement, and it is why manufacturer-supplied creative always carries the generic name in close proximity to the brand.
If you are building your own graphics rather than using supplied assets, this is the detail most likely to be dropped in the resize.
“But the manufacturer gave me the artwork”
Manufacturer co-branding programs sit on top of the federal rule and not instead of it. Two things follow.
First, supplied creative is generally built to comply, so altering it is where the risk enters. Cropping a piece of artwork to fit a story frame can remove the established name or the safety information and convert a compliant asset into a non-compliant ad under your account.
Second, the trademark terms are a separate obligation you agreed to. Losing the right to use a manufacturer’s mark is a commercial problem rather than a regulatory one, and it happens faster than an enforcement letter.
Where the FDA rule ends and the other rules begin
Section 202.1 is one of at least four regimes running on the same post.
- Who may perform the treatment. Advertising a service you are not staffed to deliver lawfully is its own exposure. See who can inject, by state.
- Claims and endorsements. Results claims, influencer posts and testimonials answer to the Federal Trade Commission. See FTC rules for testimonials and influencers.
- Patient images. A before-and-after photo is a marketing use of protected health information. See before-and-after photo rules.
- What “approved” means. Saying a product is FDA approved when it is approved for something else, or not at all, is a claim about the approval itself. See what FDA approved means.
A single post can breach all four. They are usually written by whoever runs the account.
A four-question test before the post goes up
- Does the copy name a prescription drug? If no, § 202.1 does not apply, and you are in ordinary advertising law.
- If it names the drug, does it state an indication or a dosage? If no, you may be inside the reminder-advertisement exemption. If yes, you are not.
- If you are outside the exemption, where is the brief summary? Side effects, contraindications and effectiveness, presented truthfully.
- Does the established name appear with the proprietary name? In the asset as published, at the size it publishes.
What this means for you
Decide deliberately whether you are advertising a drug or a service, because the second is far simpler to run. Where you do name the product, use manufacturer-supplied creative unaltered, and treat any crop or resize as a change that needs re-checking. Give one person ownership of the account and the rule set rather than letting three people post from their phones. And go back through what is already live: the ads running today were written under whatever understanding you had then, and they are still advertising now.
Related reading
Frequently asked questions
Can I say “Botox” in my advertising?
Yes, with conditions. 21 CFR § 202.1(e)(2)(i) exempts reminder advertisements, which name the drug but include no indication or dosage recommendation. Adding what the drug treats takes the ad out of that exemption and triggers the brief summary requirement in § 202.1(e)(1).
What is a reminder advertisement?
An advertisement that calls attention to the name of a drug product without stating indications or dosage recommendations. It may contain only the proprietary name, the established name of the product, and the established name of each active ingredient, plus a few optional items such as dosage form.
Is it easier to advertise the treatment without naming the brand?
Generally yes. An advertisement for a service that does not identify a prescription drug is not a prescription-drug advertisement, so § 202.1 does not apply. Ordinary advertising law and the claim rules still do.
Do I have to include the generic name next to the brand name?
Where the advertisement names the product, § 202.1 requires the established name to accompany the proprietary name. This is a federal requirement rather than a manufacturer preference, and it is the element most often lost when creative is resized or cropped.
Does using manufacturer-supplied artwork make my ad compliant?
Only while it is unaltered. Supplied creative is generally built to comply, so cropping or resizing can remove the established name or safety information and turn a compliant asset into a non-compliant advertisement published under your account.
This is general information, not legal advice. Rules vary by state and change. Confirm your own facts with counsel.